News

Immunicom Introduces 2nd Product of Immunopheresis® Therapy Platform Designed to Suppress Cancer Progression and Overcome Therapeutic Resistance

Immunotherapy device intended to safely filter-out IL-6 cytokine through novel subtractive therapy Initiation of pre-clinical program is critical first step...

Skye Bioscience Announces THCVHS Late-Breaking Preclinical Abstracts Selected by American Association of Pharmaceutical Scientists Meeting PharmSci 360

SAN DIEGO, CA, Sept. 21, 2021 (GLOBE NEWSWIRE) --  Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a biopharmaceutical company developing proprietary...

error: Content is protected !!